Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion
Bitget2026/10/21 10:04- Elevance Health’s third-quarter 2026 diluted earnings rose 18% year over year to $6.27 per share.
- Operating revenue increased year over year to $50.44 billion, supported by higher premium yields, CarelonRx product revenue and service fees.
- Health Benefits operating gain fell 27% year over year to $436 million, reflecting targeted investments supporting its long-term operating model.
- The full-year 2026 outlook calls for diluted earnings of at least $22 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm lays off hundreds of employees across California

Anthropic has not yet gone public, but 20 leveraged ETFs have already "jumped the gun"
More than 20 leveraged ETF products focused on Anthropic have already completed early filings in the United States prior to listing, with issuers including Direxion, ProShares, and GraniteShares. Competition is intensifying even before the IPO. First-mover advantage is critical; after SpaceX went public, out of 14 related products, only one reached assets under management of over 100 million USD. The "winner-takes-all" effect is driving issuers to rush to market.

Commonwealth Bank of Australia invests in its own computing power to advance AI

Ethereum Foundation: Sells another 1,200 ETH worth approximately $2.14 million
